Regression of Sight-Threatening Macular Edema in Type 2...

Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti-Tumor Necrosis Factor Monoclonal Antibody Infliximab

Sfikakis, P. P., Markomichelakis, N., Theodossiadis, G. P., Grigoropoulos, V., Katsilambros, N., Theodossiadis, P. G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/diacare.28.2.445
Date:
February, 2005
File:
PDF, 694 KB
english, 2005
Conversion to is in progress
Conversion to is failed